Evidence 1
Activity
Activity
10% Hemolysis
Toxicity
13.7 µM
Hemolytic
Cytotoxic
10% Hemolysis | 13.7 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Design of antimicrobial peptide arenicin analogs with improved therapeutic indices. | J Pept Sci | 2015